Maria Gemelli

6PUBLICATIONS
21CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 06, 2024
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients.

Matteo Villa, Federica Malighetti, Elisa Sala

|Jul 11, 2023
Immune-related gigantomastia: a case study.

Alessia Lozito, Maria Gemelli, Donata Micello

|Dec 23, 2022
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis.

Maria Gemelli, Diego Luigi Cortinovis, Alice Baggi

|Dec 07, 2021
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature.

Maria Gemelli, Marco Carbone, Maria I Abbate

|Apr 30, 2021
Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience.

Lavinia Monaco, Maria Gemelli, Irene Gotuzzo

|Apr 03, 2021
Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma.

Diego Cortinovis, Paolo Bidoli, Stefania Canova

Pageof 1

Frequent Collaborators

4 joint publications

Diego Luigi Cortinovis

1 joint publications

Maria Luisa Lavitrano

1 joint publications

Giuseppe Luigi Banna

1 joint publications

Stephen V Liu